510(k) is a premarket notification submitted to the U.S. Food and Drug Administration to demonstrate that a medical device is substantially equivalent to an already legally marketed predicate device. In regulatory affairs and translation work, it appears in submission dossiers, device descriptions, indications, and labeling that must be prepared in English or aligned with U.S. submission language for market clearance by the agency.
Translators encounter 510(k) terminology when localizing regulatory dossiers, device descriptions, intended-use statements, and labeling for U.S.-bound submissions. The term often appears alongside predicate-device comparisons, indications, and performance data; translators must keep medical claims consistent with FDA submission language, approved indications, and the terminology used in the source engineering documentation received from the manufacturer.
A common error is translating 'substantial equivalence' as 'identical' or treating 510(k) as an approval rather than a clearance. This misrepresents the regulatory status and can affect marketing or labeling claims; inconsistent use of 'predicate device' also confuses reviewers and may trigger additional questions during the submission process from the agency.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →